Answers are grounded in this paper and cite their sources.
Our data suggest that AD pathology increases susceptibility to diabetes due to impaired hypothalamic insulin signaling, and that plasma BCAA levels could serve as a biomarker of hypothalamic insulin action in patients with AD.
No takes yet. Share an insight, caveat, or question.
Ruiz et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: